Pulmonx Corp
For the period ended Dec 31, 2025. Filed Mar 10, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Redwood City, State of California, on the 10th day of March, 2026.
| PULMONX CORPORATION | ||
| By: | /s/ Glendon E. French | |
|---|---|---|
| Glendon E. French | ||
| President, Chief Executive Officer and Director | ||
| By: | /s/ Derrick Sung | |
| Derrick Sung, Ph.D. | ||
| Chief Operating Officer and Chief Financial Officer | ||
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Glendon E. French and Derrick Sung, jointly and severally, as his or her true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him or her and in his or her name, place, and stead, in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming that all said attorneys-in-fact and agents, or his or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this Annual Report on Form 10-K has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated:
| Signature | Title | Date |
|---|---|---|
| /s/ Glendon E. French | President, Chief Executive Officer and Director | March 10, 2026 |
| Glendon E. French | (Principal Executive Officer) | |
| /s/ Derrick Sung | Chief Operating Officer and Chief Financial Officer | March 10, 2026 |
| Derrick Sung, Ph.D. | (Principal Financial Officer and Principal Accounting Officer) | |
| /s/ Thomas W. Burns | Director | March 10, 2026 |
| Thomas W. Burns | ||
| /s/ Richard Ferrari | Director | March 10, 2026 |
| Richard Ferrari | ||
| /s/ Daniel P. Florin | Director | March 10, 2026 |
| Daniel P. Florin | ||
| /s/ Georgia Garinois-Melenikiotou | Director | March 10, 2026 |
| Georgia Garinois-Melenikiotou | ||
| /s/ Dana G. Mead, Jr. | Director | March 10, 2026 |
| Dana G. Mead, Jr. | ||
| /s/ Tiffany Sullivan | Director | March 10, 2026 |
| Tiffany Sullivan | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.